Torque Teno Virus plasma DNA load: a novel prognostic biomarker in CAR-T therapy-Reference-Cited by-同舟云学术

Torque Teno Virus plasma DNA load: a novel prognostic biomarker in CAR-T therapy

Published:2023-11-02 Issue:1 Volume:59 Page:93-100
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Benzaquén Ana^ORCID,Giménez Estela,Iacoboni Gloria,Guerreiro Manuel^ORCID,Hernani Rafael,Albert Eliseo,Carpio Cecilia^ORCID,Balaguer Aitana,Pérez Ariadna,S de la Asunción Carlos,Sánchez-Salinas Mario Andrés,Chorão Pedro^ORCID,Piñana José Luis^ORCID,Beas Francisco,Montoro Juan^ORCID,Hernández-Boluda Juan Carlos^ORCID,Facal Ana,Ferrer Blanca,Villalba Marta,Amat Paula,Goméz María Dolores,Campos Diana,Terol María José,Sanz Jaime^ORCID,Barba Pere,Navarro David^ORCID,Solano Carlos^ORCID

Funder

Fundación Española de Hematología y Hemoterapia

Gilead Sciences

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-023-02114-0.pdf

Reference44 articles.

1. Huang J, Huang X, Huang J. CAR-T cell therapy for hematological malignancies: limitations and optimization strategies. Front Immunol. 2022;13:1019115.

2. Patel U, Abernathy J, Savani BN, Oluwole O, Sengsayadeth S, Dholaria B. CAR T cell therapy in solid tumors: a review of current clinical trials. eJHaem. 2022;3:24–31.